Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria

Clinical Infectious Diseases

Volumn 40, Issue 1, 2005, Pages 28-37

  Bartosch, Sabine ^a,b   Woodmansey, Emma J ^a   Paterson, Jacqueline C M ^a   McMurdo, Marion E T ^a   Macfarlane, George T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FATTY ACID ESTER; FRUCTOSE; GELATIN; INULIN; MALTOSE; OLIGOSACCHARIDE; PLACEBO; PROBIOTIC AGENT; RAFTILOSE SYNERGYL;

AGED; AGING; ARTICLE; BACTERIAL COUNT; BACTERIUM ISOLATE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FECES MICROFLORA; FEMALE; HUMAN; HUMAN EXPERIMENT; LACTOBACILLUS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; DOUBLE-BLIND METHOD; FECES; HUMANS; MIDDLE AGED; OLIGOSACCHARIDES; POLYMERASE CHAIN REACTION; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 11144238567     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/426027     Document Type: Article

References (39)

1. Bornside GH. Stability of the human fecal flora. Am J Clin Nutr 1978; 31:S141-4.
2. Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. In: Hentges DJ, ed. Human intestinal microflora in health and disease. New York: Academic Press, 1983:3-31.
3. Macfarlane GT, Gibson GR. Metabolic activities of the normal colonic flora. In: Gibson SAW, ed. Human health: the contribution of microorganisms. London: Springer Verlag, 1994:17-52.
4. Wells CL, Maddaus MA, Jechorek RP, Simmons RL. Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 1988; 7:107-13.
5. Lovat LB. Age related changes in gut physiology and nutritional status. Gut 1996; 38:306-9.
6. Bartosch S, Fite A, Macfarlane GT, McMurdo M. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effect of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004; 70:3575-81.
7. Gavini F, Cayuela C, Antoine JM, et al. Differences in the distribution of bifidobacterial and enterobacterial species in human fecal microflora of three different (children, adults, elderly) age groups. Microb Ecol Health Dis 2001; 13:40-5.
8. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 1967; 53:845-55.
9. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48:198-205.
10. Mitsuoka T, Hayakawa K, Kimura N. Die Faekalflora bei Menschen. II. Mitteilung: Die Zusammensetzung der Bifidobakterienflora der verschiedenen Altersgruppen. Zentralbl Bakteriol [Orig A] 1974; 226:469-78.
11. Mutai M, Tanaka R. Ecology of Bifidobacterium in the human intestinal flora. Bifid Micro 1987; 6:33-11.
12. Elmer GW, McFarland LV. Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol Clin North Am 2001; 30:837-54.
13. Yamazaki S, Machii K, Tsuyuki S, Momose H, Kawashima T, Ueda K. Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invasion. Immunology 1985; 56:43-50.
14. Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T, Hashimoto Y. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumour in mice. Cancer Res 1985; 45:1300-7.
15. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-12.
16. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994; 77:412-20.
17. Gibson GR, Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 1994; 118:121-7.
18. Beerens H. Elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 1990; 11:155-7.
19. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999; 65:4506-12.
20. Malinen E, Kassinen A, Rinttila T, Palva A. Comparison of real-time PCR with SYBR Green I or 5′-nuclease assays and dot-blot hybridization with rRNA gene-targeted oligonucleotide probes in quantification of selected fecal bacteria. Microbiology 2003; 149:269-77.
21. Ventura M, Reniero R, Zink R. Specific identification and target characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol 2001; 67:2760-5.
22. Langendijk PS, Schut F, Jansen GJ, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995; 61:3069-75.
23. Bernhard AE, Field KG. Identification of nonpoint sources of fecal pollution in coastal waters by using host-specific 16S ribosomal DNA genetic markers from fecal anaerobes. Appl Environ Microbiol 2000; 66:1587-94.
24. Fujiwara S, Seto Y, Kimura A, Hashiba H. Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: its long-term survival and effect on the intestinal microflora and metabolism. J Appl Microbiol 2001; 90:43-52.
25. Bouhnik Y, Pochart P, Marteau P, Ariel G, Goderel I, Rambaud JC. Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk. Gastroenterology 1992; 102:875-8.
26. Brigidi P, Vitali B, Swennen E, Altomare L, Rossi M, Matteuzzi D. Specific detection of Bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction. Syst Appl Microbiol 2000;23:391-9.
27. Kullen MJ, Amann MM, O'Shaughnessy W, O'Sullivan DJ, Busta FF, Brady U. Differentiation of indigested bifidobacteria by DNA finger-printing demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J Nutr 1997; 127:89-94.
28. Malinen E, Matto J, Salmitie M, Alander M, Saarela M, Palva A. PCR-ELISA II: Analysis of Bifidobacterium populations in human fecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto- oligosaccharide preparation. Syst Appl Microbiol 2002; 25:249-58.
29. Alander M, Mättö J, Kneifel W, et al. Effect of galacto-oligosaccharide supplementation on human fecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Dairy J 2001; 11:817-25.
30. de Champs C, Maroncle N, Balestrino D, Rich C, Forestier C. Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol 2003; 41:1270-3.
31. Ventura M, Zink R. Rapid identification, differentiation, and proposed new taxonomic classification of Bifidobacterium lactis. Appl Environ Microbiol 2002; 68:6429-34.
32. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-78.
33. Josephon P, Gerba CP, Pepper IL. Polymerase chain reaction detection of nonviable bacterial pathogens. Appl Environ Microbiol 1993; 59:3513-5.
34. Klappenbach JA., Saxman PR, Cole JR, Schmidt TM. rrndb: The ribosomal RNA operon copy number database. Nucleic Acids Res 2001; 29:181-4.
35. He F, Ouwehand AC, Hashimoto H, Isolauri E, Benno Y, Salminen S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol Immunol 2001; 45:259-62.
36. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993; 75:373-80.
37. Tanaka R., Takayama H, Morotomi M, et al. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifid Micro 1983; 2:17-24.
38. Bouhnik Y, Flourie B, Andrieux C, Bisetti N, Briet F, Rambaud JC. Effects of Bifidobacterium sp. fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. Eur J Clin Nutr 1996; 50:269-73.
39. Roberfroid MB, Delzenne NM. Dietary fructans Annu Rev Nutr 1998; 18:117-43.